ESfEQA GmbH

What ESfEQA GmbH does

ESfEQA GmbH is a Heidelberg-based, privately held provider of External Quality Assessment (EQA) programs serving medical laboratories globally. The company holds DIN EN ISO/IEC 17043:2023 accreditation from DAkkS covering a flexible scope of proficiency testing services. Its portfolio spans five core program categories — Biochemistry, Immunoassays, Microbiology, Molecular Diagnostics, and Hematology — plus two educational programs (CASE and CASE-T), collectively covering more than 200 analytes with monthly, quarterly, and semi-annual survey cadences.

The company's technology backbone is the TEQA LAB 2.0 (TEQA 2.0) web platform, which handles participant registration, instrument/method/reagent configuration, result submission, report access, and certificate delivery. Statistical evaluation follows ISO 13528:2022-08 robust statistics with z-score-based performance grading. The product range includes specialized programs such as Tumor Markers & Hormones, SARS-CoV-2 antigen and molecular, HBV/HCV/HIV molecular, Hemogram CBC, and clozapine monitoring (CLZINS), with new programs (RESPM, anti-CCP) scheduled for Q2 2026 launch.

ESfEQA generates revenue through annual subscription-based EQA program participation fees set by its international distributor network, with direct sales only in Germany, Austria, and Switzerland. Distribution covers 50+ countries across Europe, the Americas, Africa, and Asia/Middle East. The company is independently owned (no parent company or institutional investors disclosed) under Managing Director Oliver Bošnjak and Head of Operations Dr. Dieter Groche, with no revenue, headcount, or funding figures publicly available.

Name

ESfEQA GmbH

Legal name

ESfEQA GmbH

Website

https://esfeqa.eu

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

ESfEQA GmbH is a Heidelberg-based provider of DIN EN ISO/IEC 17043-accredited External Quality Assessment (EQA) programs serving medical laboratories globally across 50+ countries via a distributor network, covering 200+ analytes across Biochemistry, Immunoassays, Microbiology, Molecular Diagnostics, Hematology, and educational programs.

Ownership category

akta.pro rank

Product category

External Quality Assessment / Proficiency Testing Services

NAICS

Testing Laboratories and Services (541380)

SIC

Services-Testing Laboratories (8734)

akta.pro primary industry

Laboratory Quality Systems, Accreditation & Proficiency Testing Programs (HLAJAIAM)

Keywords

• External quality assessment
• Proficiency testing services
• Medical laboratory EQA
• Clinical proficiency testing
• Laboratory quality control

Headquarters

HQ city

Heidelberg, Baden-Württemberg

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Annual EQA Program Participation Fees: Laboratories pay participation fees for EQA programs ordered for a full calendar year. Fees are set by distributors in their geographical areas and vary due to shipping, handling, and customs costs. Programs are offered with 2, 4, or 12 surveys per year.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

ESfEQA provides External Quality Assessment (proficiency testing) programs for medical laboratories across biochemistry, immunoassays, microbiology, molecular diagnostics, and hematology. Laboratories receive standardized control samples, submit analytical results through the TEQA LAB 2.0 platform, and receive ISO 13528-based statistical evaluations to verify analytical performance and support ISO 15189 accreditation compliance.

Product overview

ESfEQA GmbH offers a comprehensive portfolio of External Quality Assessment (EQA) programs for medical laboratories across six main categories: Biochemistry, Immunoassays, Microbiology, Molecular Diagnostics, Hematology, and Educational Programs. The company's core offerings include specialized EQA programs such as Biochemistry panels (cardiac markers, clinical chemistry, coagulation), Microbiology testing (virology, bacteriology, parasitology serology), Immunoassays (hormones, tumor markers, specific proteins), Molecular Diagnostics (HBV, HCV, HIV, SARS-CoV-2), and Hematology (hemogram with differential). ESfEQA also provides educational offerings through the CASE (Clinical Case Study Program) and CASE-T (Case Studies in Clinical Laboratory Science) programs. All programs are supported by the TEQA LAB 2.0 web platform for participant result submission, reporting, and certificate management. Programs are conducted monthly, quarterly, or semi-annually with high-quality samples, professional statistical analysis, and transparent evaluation based on ISO 13528 standards.

Differentiator

Problem solved

Functional benefit

Brands

• TEQA LAB 2.0: Web application for EQA participants to submit results, access reports, and manage program participation
• CASE
• CASE-T

Products and services

• Biochemistry EQA Programs

Quantifiable outcome

• Reports delivered within 10 days for monthly programs, 3 weeks for quarterly/semi-annual programs after result submission deadline

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered minor.

• IONOS SEminorOthersWeb hosting provider for ESfEQA's website. Server log files collected include IP address, device info, browser type, requested files, time of access, and data volume.
• Freshworks GmbHminorOthersChat tool provider for website visitor communications. Enables quick response to enquiries. Data processing requires explicit user consent.
• Usercentrics GmbHminorOthersConsent management tool for GDPR compliance, managing cookie consents and external service permissions on the website.
• Google Ireland LimitedminorOthersProvider of Google Fonts (web typography) and Google Analytics (web analytics) with Google Tag Manager for tag management.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• College of American Pathologists (CAP): CAP operates large-scale proficiency testing programs (and laboratory accreditation) primarily in North America. It overlaps with ESfEQA's clinical disciplines but is a broader, more established incumbent rather than a focused niche EQA provider.

Direct peers

• QCMD: QCMD (Quality Control for Molecular Diagnostics) specializes in EQA for infectious disease molecular testing, closely overlapping with ESfEQA's Molecular Diagnostics programs (HBV, HCV, HIV, SARS-CoV-2, RESPM). It is a key direct competitor in the molecular EQA niche.
• QualiCont: QualiCont provides EQA/proficiency testing services with international reach, including programs in clinical chemistry and microbiology. It competes with ESfEQA for laboratory customers across Latin America, Europe, and other regions.
• BIO-RAD Laboratories: BIO-RAD's Unity Real Time and Unity Interlaboratory programs are among the largest global EQA/proficiency testing services, covering chemistry, immunoassay, microbiology, molecular, and hematology. It is the closest direct competitor to ESfEQA's portfolio and global distribution model.
• UK NEQAS: UK NEQAS is one of the largest international EQA scheme operators, covering the majority of the same disciplines as ESfEQA (biochemistry, immunology, microbiology, molecular, hematology). It is a direct competitor for global laboratory subscriptions.
• Referenzinstitut für Bioanalytik (RfB): RfB is a German EQA provider affiliated with the DGKL, operating proficiency testing schemes in clinical chemistry and related disciplines. It directly competes with ESfEQA's biochemistry and immunoassay EQA programs, particularly in Germany.
• INSTAND e.V. INSTAND is a long-established German provider of EQA/proficiency testing programs for medical laboratories under recognized accreditation. It is a direct competitor in the DACH market and across multiple disciplines that overlap with ESfEQA's portfolio.
• Labquality: Labquality is a Finnish-based, internationally operating EQA provider offering programs across clinical chemistry, microbiology, and molecular diagnostics. It competes head-to-head with ESfEQA for European laboratory customers and operates a similar multi-distributor model.
• One World Accuracy: One World Accuracy is an international EQA provider with a similar distributor-driven global model, competing with ESfEQA in clinical chemistry and immunoassay proficiency testing across multiple regions.

Emerging players

• ECAT (European Concerted Action on Thrombosis): ECAT provides international proficiency testing for thrombosis and hemostasis, an adjacent specialty that overlaps with parts of ESfEQA's coagulation and hematology offerings. It is a focused niche competitor rather than a broad EQA provider.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/esfeqa-gmbh

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ESfEQA GmbH